Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

1.

Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines.

Brandt SD, Elliott SP, Kavanagh PV, Dempster NM, Meyer MR, Maurer HH, Nichols DE.

Rapid Commun Mass Spectrom. 2015 Apr 15;29(7):573-84. doi: 10.1002/rcm.7134.

PMID:
26212274
2.
3.

Nicolaus Copernicus and the rapid vascular responses to aldosterone.

Barton M, Meyer MR.

Trends Endocrinol Metab. 2015 Jun 15. pii: S1043-2760(15)00087-9. doi: 10.1016/j.tem.2015.05.005. [Epub ahead of print]

PMID:
26088671
4.

Lucy's back: Reassessment of fossils associated with the A.L. 288-1 vertebral column.

Meyer MR, Williams SA, Smith MP, Sawyer GJ.

J Hum Evol. 2015 Aug;85:174-80. doi: 10.1016/j.jhevol.2015.05.007. Epub 2015 Jun 6.

PMID:
26058822
5.

Evidence for intermolecular interactions between the intracellular domains of the arabidopsis receptor-like kinase ACR4, its homologs and the Wox5 transcription factor.

Meyer MR, Shah S, Zhang J, Rohrs H, Rao AG.

PLoS One. 2015 Mar 10;10(3):e0118861. doi: 10.1371/journal.pone.0118861. eCollection 2015.

6.

Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques.

Welter J, Brandt SD, Kavanagh P, Meyer MR, Maurer HH.

Anal Bioanal Chem. 2015 May;407(12):3457-70. doi: 10.1007/s00216-015-8552-2. Epub 2015 Feb 25.

PMID:
25711990
7.

P-glycoprotein interactions of novel psychoactive substances - stimulation of ATP consumption and transport across Caco-2 monolayers.

Meyer MR, Wagmann L, Schneider-Daum N, Loretz B, de Souza Carvalho C, Lehr CM, Maurer HH.

Biochem Pharmacol. 2015 Apr 1;94(3):220-6. doi: 10.1016/j.bcp.2015.01.008. Epub 2015 Jan 28.

PMID:
25637762
8.

G protein-coupled estrogen receptor protects from atherosclerosis.

Meyer MR, Fredette NC, Howard TA, Hu C, Ramesh C, Daniel C, Amann K, Arterburn JB, Barton M, Prossnitz ER.

Sci Rep. 2014 Dec 23;4:7564. doi: 10.1038/srep07564.

9.

Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.

Welter J, Kavanagh P, Meyer MR, Maurer HH.

Anal Bioanal Chem. 2015 Feb;407(5):1371-88. doi: 10.1007/s00216-014-8360-0. Epub 2014 Dec 4.

PMID:
25471293
10.

Witnessed drug intake before planned denervation--always harmless?

Linicus Y, Kindermann I, Helfer AG, Meyer MR, Maurer HH, Mahfoud F, Böhm M.

Int J Cardiol. 2015 Jan 20;179:125-6. doi: 10.1016/j.ijcard.2014.10.162. Epub 2014 Oct 28. No abstract available.

PMID:
25464430
11.

Contribution of human esterases to the metabolism of selected drugs of abuse.

Meyer MR, Schütz A, Maurer HH.

Toxicol Lett. 2014 Oct 24;232(1):159-166. doi: 10.1016/j.toxlet.2014.10.026. [Epub ahead of print]

PMID:
25445008
12.

Prospective risk of fetal death with gastroschisis.

Meyer MR, Shaffer BL, Doss AE, Cahill AG, Snowden JM, Caughey AB.

J Matern Fetal Neonatal Med. 2014 Dec 23:1-4. [Epub ahead of print]

PMID:
25428833
13.

In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach.

Dinger J, Meyer MR, Maurer HH.

Arch Toxicol. 2014 Nov 23. [Epub ahead of print]

PMID:
25417051
14.

Current position of high-resolution MS for drug quantification in clinical & forensic toxicology.

Meyer MR, Helfer AG, Maurer HH.

Bioanalysis. 2014 Aug;6(17):2275-84. doi: 10.4155/bio.14.164. Review.

PMID:
25383737
15.

Forensic and clinical toxicology.

Meyer MR, Maurer HH.

Bioanalysis. 2014 Aug;6(17):2187. doi: 10.4155/bio.14.193. No abstract available.

16.

Instrumentation for the detection and characterization of exoplanets.

Pepe F, Ehrenreich D, Meyer MR.

Nature. 2014 Sep 18;513(7518):358-66. doi: 10.1038/nature13784.

PMID:
25230658
17.

Preference toward future mode of delivery: how do antepartum preferences and prior delivery experience contribute?

Sparks TN, Yeaton-Massey A, Granados JM, Handler SJ, Meyer MR, Caughey AB.

J Matern Fetal Neonatal Med. 2014 Oct 6:1-6. [Epub ahead of print]

PMID:
25212977
18.

Trends in analyzing emerging drugs of abuse--from seized samples to body samples.

Meyer MR.

Anal Bioanal Chem. 2014 Oct;406(25):6105-10. doi: 10.1007/s00216-014-8082-3. Epub 2014 Aug 17. Review.

PMID:
25129635
19.

Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n).

Wink CS, Meyer MR, Braun T, Turcant A, Maurer HH.

Anal Bioanal Chem. 2015 Jan;407(3):831-43. doi: 10.1007/s00216-014-8083-2. Epub 2014 Aug 14.

PMID:
25120185
20.

Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse.

Dinger J, Meyer MR, Maurer HH.

Toxicol Lett. 2014 Oct 1;230(1):28-35. doi: 10.1016/j.toxlet.2014.08.004. Epub 2014 Aug 8.

PMID:
25111188
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk